Agios Pharmaceuticals (United States)
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Agios Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
583
Total Open
Publications
270
Total
Citations
45K
Open Access
Percentage
46%
Total
Publications
583
Total Open
Publications
270
Total
Citations
45K
Breakdown
Publisher Open
12%
Both
25%
Other Platform Open
8%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 46%
97
Hybrid 18%
39
No Guarantees 36%
75
Other Platform Open
Domain 86%
167
Institution 14%
27
Other Internet 14%
27
Public 2%
3
Preprint 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 169 |
DOI | Other Internet | 26 |
DANS - Data Archiving and Networked Services | Institution | 6 |
Europe PMC | Domain | 4 |
Universite de Bordeaux - Oskar-Bordeaux | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
DASH - Digital Access to Scholarship at Harvard | Institution | 3 |
Utrecht University - Utrecht University Repository | Institution | 2 |
University of Padua - Padua Research Archive | Institution | 2 |
University of Michigan - Deep Blue | Institution | 2 |